32.54 -0.67 (-2.02%)

38.91% Fall from 52W High

868.2K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Kymera Therapeutics Inc - KYMR - stock price prediction, stock price target, analyst ratings from 20 analysts

Kymera Therapeutics Inc has a share price target of US$ 58, revenue growth forecast of 32.7%, and profit growth estimate of -33.3% for FY25, based on top 20 analyst calls.